
Advitam Life Sciences Private Limited
About Advitam Life Sciences Private Limited
Data last updated:
Advitam Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2016PTC307742. Its GSTIN is 07AAOCA8736C1ZJ (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Neelam Bagwar and Sudhakar Arya.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 407 Pragati Towers Rajendra Place, New Delhi, Delhi, India – 110008.
As per the financials filed for FY 2022, the company reported a revenue of ₹72.9 Lakh, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹6.86 Lakh (net margin 9.4%) and EBITDA of ₹9.97 Lakh (EBITDA margin 13.7%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Advitam Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address407 Pragati Towers Rajendra Place, New Delhi, Delhi, India – 110008
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Advitam Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Advitam Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Advitam Life Sciences Private Limited, buy the company report.
Financials of Advitam Life Sciences Private Limited
FY 2022 filings availableAdvitam Life Sciences Private Limited reported revenue of ₹72.9 Lakh (up 27% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 34% over three years, including 27% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.97 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.7% | ||||
| Net Profit Margin | 9.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Advitam Life Sciences Private Limited, buy the company report.
Board of directors of Advitam Life Sciences Private Limited
Advitam Life Sciences has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelam Bagwar | Director | 31 Oct 2016 | 10 Years 0 Months | Current |
| Sudhakar Arya Also directs: Jenome Biophar Private Limited | Director | 31 Oct 2016 | 10 Years 0 Months | Current |
| Astha Munjal Also directs: Shine Consultants LLP, Sda Engineering Private Limited | Director | 31 Oct 2016 | 10 Years 0 Months | Current |
| Rakesh Jain Kumar Also directs: Sidhayatan Health Care Foundation | Director | 31 Oct 2016 | 10 Years 0 Months | Current |
Peer comparison
Advitam Life Sciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abia Pharmaceuticals Private Limited | ₹73.13 Lakh (FY 2024) | -70.0% | Chennai, Tamil Nadu, India | |||
| Pci Bioscience Private Limited | ₹73.08 Lakh (FY 2024) | -14.0% | Mandi Adampur, Haryana, India | |||
| Caraway Pharma Private Limited | ₹72.97 Lakh (FY 2021) | -54.0% | Madurai, Tamil Nadu, India | |||
| Nectar Healthscience Private Limited | ₹72.96 Lakh (FY 2025) | 118.0% | Agra, Uttar Pradesh, India | |||
| Advitam Life Sciences Private Limitedthis company | ₹72.9 Lakh (FY 2022) | ₹6.86 Lakh | 9.4% | 27.0% | New Delhi, Delhi, India | |
| Sloventis Pharma Private Limited | ₹72.66 Lakh (FY 2024) | 11.0% | Nadia, West Bengal, India | |||
| Icon Lifecare Private Limited | ₹72.54 Lakh (FY 2024) | 21.0% | Hathras, Uttar Pradesh, India | |||
| Studdmed Healthcare Private Limited | ₹72.53 Lakh (FY 2025) | 90.0% | Tarapur, Assam, India |
To see the full peer comparison of Advitam Life Sciences Private Limited, buy the company report.
Auditor
Advitam Life Sciences Private Limited is audited by ROHIT TANDON & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ROHIT TANDON & ASSOCIATES | FY 2021 | 018438C |
Shareholding
The shareholding of Advitam Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Advitam Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Advitam Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Advitam Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Advitam Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAOCA8736C1ZJ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Advitam Life Sciences Private Limited, buy the company report.
Recent activity
Advitam Life Sciences Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Astha Munjal was appointed as Director on 31 Oct 2016.
Frequently asked questions
Advitam Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 October 2016 (10+ years old) and is registered under CIN U51909DL2016PTC307742.
Advitam Life Sciences has 4 current directors:
- Neelam Bagwar - Director
- Sudhakar Arya - Director
- Astha Munjal - Director
- Rakesh Jain Kumar - Director
The latest financial statements of Advitam Life Sciences on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Advitam Life Sciences is 07AAOCA8736C1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Advitam Life Sciences is U51909DL2016PTC307742. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Advitam Life Sciences was incorporated on 31 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Advitam Life Sciences by revenue are Abia Pharmaceuticals Private Limited, Pci Bioscience Private Limited, Caraway Pharma Private Limited, Nectar Healthscience Private Limited, Sloventis Pharma Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Astha Munjal was appointed as Director on 31 Oct 2016. Neelam Bagwar was appointed as Director on 31 Oct 2016. Rakesh Jain Kumar was appointed as Director on 31 Oct 2016. Advitam Life Sciences has 4 board changes on record in total.
The registered office of Advitam Life Sciences is at 407 Pragati Towers Rajendra Place, New Delhi, Delhi, India – 110008.
Advitam Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Advitam Life Sciences is compliant as of 14 August 2026. The company is actively filing with the Registrar of Companies.

